Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
IsraelIPO:
21 August 2020Website:
http://www.nanox.visionNext earnings report:
21 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 6 min agoDividend
Analysts recommendations
Institutional Ownership
NNOX Latest News
PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2024, before market open on Thursday, November 21, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Company management will participate in an investor conference in the month of September 2024:
HealthCCSng V2.0 i ntroduces additional ‘ zero calcium ' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC d etection c ategory output
Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to expand Nanox.ARC indications to include general use, including chest Nanox.AI Receives FDA 510K Clearance for HealthCCSng V 2.0, upgraded version of its AI Cardiac Solution Management to host conference call and webcast Tuesday, August 20, 2024 at 8:30 AM ET PETAH TIKVA, Israel, Aug. 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2024 and provided a business update. Recent Highlights: Generated $2.7 million in revenue in the second quarter of 2024, compared to $2.6 million in the second quarter of 2023.
Nano-X Imaging is especially popular with analysts. Recursion Pharmaceuticals plans to report results from seven clinical studies over the next 18 months.
Here is how Nano-X Imaging Ltd. (NNOX) and Parsons (PSN) have performed compared to their sector so far this year.
PETACH TIKVA, Israel, June 25, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography (SCCT), being held July 18-21 in Washington, D.C.
Here is how Nano-X Imaging Ltd. (NNOX) and Seagate (STX) have performed compared to their sector so far this year.
NanoX Imaging (NNOX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service
What type of business is Nano-X Imaging?
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.
What sector is Nano-X Imaging in?
Nano-X Imaging is in the Healthcare sector
What industry is Nano-X Imaging in?
Nano-X Imaging is in the Medical Devices industry
What country is Nano-X Imaging from?
Nano-X Imaging is headquartered in Israel
When did Nano-X Imaging go public?
Nano-X Imaging initial public offering (IPO) was on 21 August 2020
What is Nano-X Imaging website?
https://www.nanox.vision
Is Nano-X Imaging in the S&P 500?
No, Nano-X Imaging is not included in the S&P 500 index
Is Nano-X Imaging in the NASDAQ 100?
No, Nano-X Imaging is not included in the NASDAQ 100 index
Is Nano-X Imaging in the Dow Jones?
No, Nano-X Imaging is not included in the Dow Jones index
When was Nano-X Imaging the previous earnings report?
No data
When does Nano-X Imaging earnings report?
The next expected earnings date for Nano-X Imaging is 21 November 2024